Historical record - last NADAC effective date: 7/20/2016
Product Information
TOPIRAMATE ER 100 MG CAPSULE is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $10.0682 per EA under NDC 00832107415. Its NADAC has been published 109 times since Jul 22, 2015.
FDA first approved this application on Mar 11, 2014. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
00832107415
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
7/20/2016
Active Ingredients
TOPIRAMATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA205122FDA Approved
3/11/2014
TE Code
AB2
On Market Since
7/7/2014
Pharmacological Classes
Price Statistics
The NADAC for TOPIRAMATE ER 100 MG CAPSULE has been published 109 times since Jul 22, 2015, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.0682 per EA |
|---|---|
| All-time high | $10.1196 (Jul 13, 2016) |
| All-time low | $10.0682 (Jul 20, 2016) |
| Median price | $10.0682 |
| Average price | $10.0927 |
| Largest weekly change | -0.5% (Jul 20, 2016) |
| Weeks tracked | 109 |
| Tracking since | Jul 22, 2015 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-0.5%
Last surveyed Aug 16, 2017 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 47% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TOPIRAMATE ER 100 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE ER 100 MG CAPSULE, manufactured by Upsher-Smith Laboratories LLC, is $10.0682 per EA (NDC 00832107415), effective Aug 16, 2017.
How has the price of TOPIRAMATE ER 100 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TOPIRAMATE ER 100 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 109 weekly CMS publications since Jul 22, 2015.
What are the highest and lowest recorded NADAC prices for TOPIRAMATE ER 100 MG CAPSULE?
Since Jul 22, 2015, the NADAC for TOPIRAMATE ER 100 MG CAPSULE has ranged from a low of $10.0682 (Jul 20, 2016) to a high of $10.1196 (Jul 13, 2016), with a median of $10.0682 per EA.
Are there cheaper alternatives to TOPIRAMATE ER 100 MG CAPSULE?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TOPIRAMATE ER 100 MG SPRINK CAP, is $5.3819 per EA — about 47% below TOPIRAMATE ER 100 MG CAPSULE.
Who manufactures TOPIRAMATE ER 100 MG CAPSULE?
TOPIRAMATE ER 100 MG CAPSULE (NDC 00832107415) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.